Tower Research Capital (TRC)’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $41.2K | Sell |
|
|||||
|
2025
Q2 | $71.8K | Buy |
|
|||||
|
2025
Q1 | $36.8K | Sell |
|
|||||
|
2024
Q4 | $328K | Buy |
|
|||||
|
2024
Q3 | $218K | Sell |
|
|||||
|
2024
Q2 | $270K | Buy |
|
|||||
|
2024
Q1 | $385K | Buy |
|
|||||
|
2023
Q4 | $110K | Buy |
|
|||||
|
2023
Q3 | $60.4K | Buy |
|
|||||
|
2023
Q2 | $82.6K | Sell |
|
|||||
|
2023
Q1 | $76K | Sell |
|
|||||
|
2022
Q4 | $201K | Sell |
|
|||||
|
2022
Q3 | $539K | Buy |
|
|||||
|
2022
Q2 | $281K | Buy |
|
|||||
|
2022
Q1 | $48K | Buy |
|
|||||
|
2021
Q4 | $6K | Sell |
|
|||||
|
2021
Q3 | $17K | Sell |
|
|||||
|
2021
Q2 | $92K | Sell |
|
|||||
|
2021
Q1 | $2.77M | Buy |
|
|||||
|
2020
Q4 | $1.64M | Buy |
|
|||||
|
2020
Q3 | $121K | Sell |
|
|||||
|
2020
Q2 | $625K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $8K | Sell |
|
|||||
|
2019
Q3 | $112K | Buy |
|
|||||
|
2019
Q2 | $29K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $99K | Buy |
|
|||||
|
2018
Q2 | $16K | Buy |
|
|||||
|
2018
Q1 | $1K | Sell |
|
|||||
|
2017
Q4 | $5K | Sell |
|
|||||
|
2017
Q3 | $71K | Buy |
|
|||||
|
2017
Q2 | $2K | Buy |
|
|||||
|
2017
Q1 | $1K | Sell |
|
|||||
|
2016
Q4 | $33K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $3K | Sell |
|
|||||
|
2015
Q3 | $14K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $45K | Buy |
|